BMJ  2003;327:5-6 (5 July), doi:10.1136/bmj.327.7405.5

Editorial

INRs and point of care testing

Despite limitations, overall evidence shows that point of care testing is reliable

The first 150 words of the full text of this article appear below.

The development and adoption of instruments for determining the international normalised ratio (INR) at the point of care for monitoring treatment with coumarin anticoagulants has added another variable to the question of the precision of INR measurements. In this issue Poller et al (p 30) show discrepancies between results when two such instruments are used and the best estimate of the true INR.1 These observations, however, should be seen in the context of the already recognised limitations of the INR system and the potential for using point of care testing to deliver safe and effective anticoagulant therapy efficiently.

Coumarin anticoagulants remain the preferred method of prophylaxis and treatment for thrombosis in a range of clinical situations. Around 1% of the populations of many countries receive such treatment, a proportion boosted by the increasing use of oral anticoagulation as thromboprophylaxis in atrial fibrillation.2 Monitoring of the anticoagulant effect of . . . [Full text of this article]

ET Murray, research fellow

Department of General Practice, University of Birmingham, Edgbaston, Birmingham B15 2TT

M Greaves, professor

Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods
Leon Poller, Michelle Keown, Nikhil Chauhan, Anton MHP van den Besselaar, Armando Tripodi, Caroline Shiach, and Jorgen Jespersen
BMJ 2003 327: 30. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., Palareti, G. (2008). Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 160S-198S [Abstract] [Full text]  
  • Claxton, N., Griffin, L. (2006). A forgotten tribe: a survey of the experience of working as a non-consultant career grade psychiatrist. Psychiatr. Bull. 30: 369-372 [Abstract] [Full text]  
  • Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., Hylek, E. (2004). The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 204S-233S [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Letīs follow the example of diabetes care
Iņigo Romon-Alonso
bmj.com, 4 Jul 2003 [Full text]
Community-based solutions for community-based problems
Preeti Choudhary, et al.
bmj.com, 22 Jul 2003 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ